A randomized trial found that using a natural cycle to prepare the endometrium for frozen embryo transfer in ovulatory women led to higher live birth rates and fewer complications compared to hormone replacement therapy.
FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.
A large Danish study found that newborns with early-onset sepsis had a higher chance of developing autism later in life, while the link to ADHD was weaker when familial factors were considered.
Newborns have higher levels of phosphorylated tau217 in their blood than even patients with Alzheimer’s disease, a new study finds, raising new questions about the dual role of tau in brain development and degeneration.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.
New research highlights strong associations between metabolic syndrome and several oral diseases—including periodontitis, caries, and peri-implantitis—calling for more longitudinal studies to explore causation and improve patient care.
GAMMAGARD LIQUID ERC is the first ready-to-use liquid immunoglobulin therapy with IgA ≤2 µg/mL for primary immunodeficiency in individuals aged 2 years and older.
Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.